PMID

Data

Article Title

Organization

 

8-amino-6-(arylsulphonyl)-5-nitroquinolines: novel nonpeptide neuropeptide Y1 receptor antagonists

TBA

Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine.

University of Cincinnati Medical Center

Pharmacological treatment of obesity: therapeutic strategies.

The R. W. Johnson Pharmaceutical Research Institute

Novel modified carboxy terminal fragments of neuropeptide Y with high affinity for Y2-type receptors and potent functional antagonism at a Y1-type receptor.

Burroughs Wellcome

Highly potent antiobesity effect of a short-length peptide YY analog in mice.

Takeda Pharmaceutical